• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

信使核糖核酸(mRNA)严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫苗接种相关心肌炎的诊断——一项系统评价

Diagnostics of messenger ribonucleic acid (mRNA) severe acute respiratory syndrome-corona virus‑2 (SARS-CoV‑2) vaccination-associated myocarditis-A systematic review.

作者信息

Federspiel Jan M, Ramsthaler Frank, Kettner Mattias, Mall Gerhard

机构信息

Institute of Legal Medicine, Saarland University, Campus Homburg, Kirrbergerstraße, Geb. 49.1, 66421 Homburg Saar, Germany.

Institute of Legal Medicine, Goethe University Frankfurt Main, Kennedyallee 104, 60596 Frankfurt Main, Germany.

出版信息

Rechtsmedizin (Berl). 2023;33(2):125-131. doi: 10.1007/s00194-022-00587-9. Epub 2022 Jul 20.

DOI:10.1007/s00194-022-00587-9
PMID:35873498
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9297279/
Abstract

BACKGROUND

During the recent pandemic with the severe acute respiratory syndrome-corona virus‑2 the first messenger ribonucleic acid (mRNA) vaccines were approved. To facilitate mass vaccination, confidence of the general population in these new vaccines is mandatory, which is in turn strongly dependent on the availability of reliable data on complications.

OBJECTIVE

Summary of the current knowledge on mRNA vaccination-associated myocarditis as a potentially fatal side effect.

METHODS

Systematic literature review.

RESULTS

Diagnostic algorithm for the postmortem diagnosis of mRNA vaccination-associated myocarditis.

CONCLUSION

Autopsy series of fatalities following mRNA SARS-CoV‑2 vaccination up to 6 weeks with subsequent sophisticated and interdisciplinary work-up are necessary to complement clinical data on vaccination-associated myocarditis, especially regarding the incidence of fatal courses.

SUPPLEMENTARY INFORMATION

The online version of this article (10.1007/s00194-022-00587-9) includes a PDF file with supplemental clinical features.

摘要

背景

在最近由严重急性呼吸综合征冠状病毒2引发的大流行期间,信使核糖核酸(mRNA)疫苗获得批准。为推动大规模疫苗接种,普通民众对这些新疫苗的信心至关重要,而这又极大地依赖于有关并发症的可靠数据的可得性。

目的

总结关于mRNA疫苗接种相关心肌炎这一潜在致命副作用的现有知识。

方法

系统文献综述。

结果

mRNA疫苗接种相关心肌炎的尸检诊断算法。

结论

有必要对接种mRNA SARS-CoV-2疫苗后6周内死亡病例进行尸检系列研究,并随后进行复杂的多学科检查,以补充疫苗接种相关心肌炎的临床数据,特别是关于致命病程的发生率。

补充信息

本文的在线版本(10.1007/s00194-022-00587-9)包含一个带有补充临床特征的PDF文件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1223/9297279/7d79bd51da61/194_2022_587_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1223/9297279/7d79bd51da61/194_2022_587_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1223/9297279/7d79bd51da61/194_2022_587_Fig1_HTML.jpg

相似文献

1
Diagnostics of messenger ribonucleic acid (mRNA) severe acute respiratory syndrome-corona virus‑2 (SARS-CoV‑2) vaccination-associated myocarditis-A systematic review.信使核糖核酸(mRNA)严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫苗接种相关心肌炎的诊断——一项系统评价
Rechtsmedizin (Berl). 2023;33(2):125-131. doi: 10.1007/s00194-022-00587-9. Epub 2022 Jul 20.
2
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination.BNT162b2 和 mRNA-1273 新冠疫苗接种后的心肌炎和心包炎风险。
Vaccine. 2022 Aug 19;40(35):5153-5159. doi: 10.1016/j.vaccine.2022.07.007. Epub 2022 Jul 12.
3
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.意大利 12 至 39 岁人群接种 COVID-19 mRNA 疫苗后的心肌炎和心包炎上市后主动监测:多数据库、自身对照病例系列研究。
PLoS Med. 2022 Jul 28;19(7):e1004056. doi: 10.1371/journal.pmed.1004056. eCollection 2022 Jul.
4
Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients.两名患者在接种 BNT162b2 mRNA COVID-19 疫苗后出现暴发性心肌炎和全身炎症反应。
Int J Cardiol. 2021 Oct 1;340:119-121. doi: 10.1016/j.ijcard.2021.08.018. Epub 2021 Aug 18.
5
Risks of Myocarditis and Pericarditis Following Vaccination with SARS-CoV-2 mRNA Vaccines in Japan: An Analysis of Spontaneous Reports of Suspected Adverse Events.日本接种 SARS-CoV-2 mRNA 疫苗后心肌炎和心包炎的风险:疑似不良事件自发报告分析。
Ther Innov Regul Sci. 2023 Mar;57(2):329-342. doi: 10.1007/s43441-022-00466-1. Epub 2022 Oct 30.
6
Effect of SARS-CoV-2 mRNA-Vaccine on the Induction of Myocarditis in Different Murine Animal Models.新型冠状病毒疫苗 mRNA 对不同种属小鼠动物模型诱导心肌炎的影响。
Int J Mol Sci. 2023 Mar 6;24(5):5011. doi: 10.3390/ijms24055011.
7
The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination.mRNA COVID-19 疫苗接种后心肌炎和心包炎的极低风险不应阻止疫苗接种。
Swiss Med Wkly. 2021 Oct 19;151:w30087. doi: 10.4414/smw.2021.w30087. eCollection 2021 Oct 11.
8
Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series.mRNA COVID-19 疫苗接种后的心脏并发症:病例报告和病例系列的系统评价。
Rev Med Virol. 2022 Jul;32(4):e2318. doi: 10.1002/rmv.2318. Epub 2021 Dec 17.
9
Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.新型冠状病毒肺炎(COVID-19)疫苗接种后心肌炎和心包炎的发生率、危险因素、自然史和假设发病机制:基于实时证据的综合分析和综述。
BMJ. 2022 Jul 13;378:e069445. doi: 10.1136/bmj-2021-069445.
10
Paving the Way Towards Precision Vaccinology: The Paradigm of Myocarditis After Coronavirus Disease 2019 (COVID-19) Vaccination.为精准疫苗学铺平道路:COVID-19 疫苗接种后心肌炎范例。
Clin Infect Dis. 2022 Aug 15;75(Suppl 1):S18-S23. doi: 10.1093/cid/ciac396.

引用本文的文献

1
A Case Report: Long Post-COVID Vaccination Syndrome During the Eleven Months After the Third Moderna Dose.病例报告:第三次接种莫德纳疫苗后11个月出现的长期新冠疫苗接种综合征
Cureus. 2022 Dec 12;14(12):e32433. doi: 10.7759/cureus.32433. eCollection 2022 Dec.

本文引用的文献

1
Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms.新冠病毒 mRNA 疫苗接种后的心肌炎:临床观察及潜在机制。
Nat Rev Cardiol. 2022 Feb;19(2):75-77. doi: 10.1038/s41569-021-00662-w.
2
MODERNA mRNA-1273 vaccine-associated myopericarditis in a patient with a subclinical autoimmune predisposition.一名具有亚临床自身免疫易感性的患者发生的与Moderna mRNA-1273疫苗相关的心肌心包炎。
J Cardiol Cases. 2021 Oct 2;24(5):227-229. doi: 10.1016/j.jccase.2021.09.007. eCollection 2021 Nov.
3
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study.
SARS-CoV-2 Delta 变异株疫苗突破感染的病毒学和血清学动力学:一项多中心队列研究。
Clin Microbiol Infect. 2022 Apr;28(4):612.e1-612.e7. doi: 10.1016/j.cmi.2021.11.010. Epub 2021 Nov 23.
4
From Muscles to Wires: Report of Two Cases and Literature Review on COVID-19 Vaccination and Cardiac Conduction Disturbance.从肌肉到电线:两例报告及关于新冠疫苗接种与心脏传导障碍的文献综述
Cureus. 2021 Oct 15;13(10):e18805. doi: 10.7759/cureus.18805. eCollection 2021 Oct.
5
Delta Variants of SARS-CoV-2 Cause Significantly Increased Vaccine Breakthrough COVID-19 Cases in Houston, Texas.德爾塔變異株引發德克薩斯州休斯頓的 SARS-CoV-2 突破性疫苗突破性 COVID-19 病例顯著增加。
Am J Pathol. 2022 Feb;192(2):320-331. doi: 10.1016/j.ajpath.2021.10.019. Epub 2021 Nov 11.
6
Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs.三种已获批的 siRNA(Patisiran)和 mRNA(COVID-19 疫苗)药物中所采用的脂质纳米颗粒技术的差异。
Drug Metab Pharmacokinet. 2021 Dec;41:100424. doi: 10.1016/j.dmpk.2021.100424. Epub 2021 Oct 10.
7
Editorial Comment: Cardiac MRI as a Fundamental Tool in the Evaluation of Suspected Myocarditis After COVID-19 mRNA Vaccination in Young Patients.
AJR Am J Roentgenol. 2022 Apr;218(4):658. doi: 10.2214/AJR.21.27026. Epub 2021 Nov 10.
8
Myocarditis-induced Sudden Death after BNT162b2 mRNA COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings.韩国 BNT162b2 mRNA COVID-19 疫苗接种后心肌炎引起的猝死:病例报告重点关注组织病理学发现。
J Korean Med Sci. 2021 Oct 18;36(40):e286. doi: 10.3346/jkms.2021.36.e286.
9
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization.大型医疗机构中接种新冠疫苗后的心肌炎。
N Engl J Med. 2021 Dec 2;385(23):2132-2139. doi: 10.1056/NEJMoa2110737. Epub 2021 Oct 6.
10
Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada.评估新型 SARS-CoV-2 变种的相对毒力:加拿大安大略省的回顾性队列研究。
CMAJ. 2021 Oct 25;193(42):E1619-E1625. doi: 10.1503/cmaj.211248. Epub 2021 Oct 4.